Grant: Project Grant
Université Laval
$952,426.00
Investigating diet-rosuvastatin interactions: a controlled-feeding randomized crossover trial in primary CVD prevention.
FY 2025-26
Summary
Heart diseases remain a leading cause of death, disability, and healthcare costs. Two of the most important ways to prevent heart disease are a healthy diet and cholesterol-lowering medications, the most used being statins. Both can meaningfully improve blood cholesterol and also benefit blood pressure and inflammation. However, statins also slightly raise blood sugar, which increase long-term risk of type 2 diabetes, and diabetes itself increases long-term heart disease risk. A healthy diet, in contrast, improve blood sugar. Yet, it remains unclear how much additional benefit a healthy diet provides when someone is already taking a statin, whether these benefits differ by statin dose, and whether diet can offset statin-related worsening of blood sugar. Addressing this gap is urgent because real-world evidence suggests that starting preventive medication may reduce motivation to improve diet.
This study will quantify the benefits of combining a healthy diet with a statin at three different doses, focusing on heart disease risk and statin-related changes in blood sugar.
Ninety adults will take part. All meals will be provided to participants during the study. Each participant will complete four 4-week diet/medication interventions: a standard Canadian diet or a plant-rich diet aligned with Canada's Food Guide, each combined with either rosuvastatin or a placebo. Participants will be randomly assigned to one of three rosuvastatin dose groups (5, 10, or 20 mg/day; same dose across the study). At the end of each 4-week period, we will measure blood cholesterol, inflammation, blood pressure, and blood sugar.
This trial will generate readily usable, dose-specific evidence on how dietary improvements add to statin therapy, including whether diet can mitigate statin-related worsening of blood sugar. The findings will support sustained dietary change alongside medication and inform guideline-relevant shared decision-making about statin dosing and side-effect management.
Department
Program
Project Grant
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
563946
Name
Drouin-Chartier Jean-Philippe
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Nutrition, Food & Health
Projecttitle
Investigating diet-rosuvastatin interactions: a controlled-feeding randomized crossover trial in primary CVD prevention.
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$952,426
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cardiovascular Disease Risk; Diet; Statin; Trial
Abstract
Heart diseases remain a leading cause of death, disability, and healthcare costs. Two of the most important ways to prevent heart disease are a healthy diet and cholesterol-lowering medications, the most used being statins. Both can meaningfully improve blood cholesterol and also benefit blood pressure and inflammation. However, statins also slightly raise blood sugar, which increase long-term risk of type 2 diabetes, and diabetes itself increases long-term heart disease risk. A healthy diet, in contrast, improve blood sugar. Yet, it remains unclear how much additional benefit a healthy diet provides when someone is already taking a statin, whether these benefits differ by statin dose, and whether diet can offset statin-related worsening of blood sugar. Addressing this gap is urgent because real-world evidence suggests that starting preventive medication may reduce motivation to improve diet.
This study will quantify the benefits of combining a healthy diet with a statin at three different doses, focusing on heart disease risk and statin-related changes in blood sugar.
Ninety adults will take part. All meals will be provided to participants during the study. Each participant will complete four 4-week diet/medication interventions: a standard Canadian diet or a plant-rich diet aligned with Canada's Food Guide, each combined with either rosuvastatin or a placebo. Participants will be randomly assigned to one of three rosuvastatin dose groups (5, 10, or 20 mg/day; same dose across the study). At the end of each 4-week period, we will measure blood cholesterol, inflammation, blood pressure, and blood sugar.
This trial will generate readily usable, dose-specific evidence on how dietary improvements add to statin therapy, including whether diet can mitigate statin-related worsening of blood sugar. The findings will support sustained dietary change alongside medication and inform guideline-relevant shared decision-making about statin dosing and side-effect management.
Competitiondate
202603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Drouin-Chartier, Jean-Philippe
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $952,426~ $0~